BioNexus Gene Lab Corp Common stock
$1.39
▼ 0.09
(-6.08%)
Volume: 3,302
· 2026-09-25
Loading…
RSI (14)
🧭 Style Verdicts
🚀
Momentum
27
- 21d momentum -10.3%
- MA aligned bearish
- RSI 41
🎯
Pullback
62
- Near lower Bollinger band
- -6.1% vs 20MA
💎
Value
58
- -77% off 52w high
Scores (0–100) derived from live technical & fundamental metrics. Not investment advice.
📐 Technicals
RSI(14)41.5
MACD-0.001
MA trendBearish
ATR7.46%
21d mom.-10.3%
63d mom.-33.6%
vs 20MA-6.1%
RVOL(20)0.67×
52w low · 1
52w high · 6
-77.2% from 52-week high
20d support 1
· resistance 2
Computed live from daily OHLCV · as of 2026-09-25
🏦 Fundamentals
Market cap$4M
PER—
PBR0.56
PSR1.39
EPS$-0.88
ROE-33.1%
ROA-29.5%
Dividend yield0.00%
Debt/Equity0.01
EV/EBITDA-1.15
| week | 1M | 3M | 6M | 1Y | YTD |
|---|---|---|---|---|---|
| -11.46% | -10.32% | -33.65% | -46.41% | -74.68% | -64.72% |
Valuation and profitability in USD, latest reported 2026-09-24. Period returns are price-based.
⚖️ AI Bull vs Bear
14d momentum -4.14%, daily vol 4.02%. BioNexus Gene Lab Corp Common stock sits in a bearish regime.
Derived from 14-day momentum and daily volatility on real OHLCV.
🗞 Related News
No recent news.